Work

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

Year: 2007

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/sj.leu.2405014

Authors: M de Lima, R E Champlin, P F Thall, X Wang, T G Martin, J D Cook, G McCormick, M Qazilbash, P Kebriaei, D Couriel, E J Shpall, I Khouri, P Anderlini, C Hosing, K W Chan, B S Andersson, P A Patah, Z Caldera, E Jabbour, S Giralt

Institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2071141092

FWCI: 3.407

Cites: 29

Cited by: 50

Related to: 10